Days
Hours
Minutes
Seconds
-40%
on all subscriptions*
Last hours
Enjoy this offer
* See conditions under "Our services"

Valuation: CROSSJECT

Market Cap 103M 119M 95.81M 89.69M 168M 11.19B 169M 1.14B 440M 5.51B 445M 436M 19.13B P/E 2026 *
4.63x
P/E 2027 * 3.65x
Enterprise Value 85.54M 98.11M 79.23M 74.17M 139M 9.26B 140M 940M 364M 4.56B 368M 360M 15.82B EV / Sales 2026 *
1.41x
EV / Sales 2027 * 1.33x
Free-Float
89.86%
Yield 2026 *
-
Yield 2027 * -
Manager TitleAgeSince
Chief Executive Officer 63 08/08/2001
Director of Finance/CFO - 25/03/2026
Corporate Officer/Principal - 20/08/2024
Director TitleAgeSince
Chairman 67 26/06/2009
Director/Board Member 67 -
Director/Board Member - -
Change 5-day change 1-year change 3-year change Capi.($)
-5.03%-9.88%-20.86%-72.06% 84.41M
-8.00%-12.33%+44.01%+13.33% 75.61M
Average -6.52%-11.11%+11.58%-29.36% 80.01M
Weighted average by Cap. -6.43%-11.04%+9.79%-31.71%

Financials

2026 *2027 *
Net sales 60.8M 69.73M 56.31M 52.71M 98.86M 6.58B 99.46M 668M 259M 3.24B 262M 256M 11.25B 42.3M 48.51M 39.18M 36.67M 68.78M 4.58B 69.2M 465M 180M 2.25B 182M 178M 7.82B
Net income 28.3M 32.46M 26.21M 24.54M 46.02M 3.06B 46.29M 311M 121M 1.51B 122M 119M 5.23B 7.75M 8.89M 7.18M 6.72M 12.6M 839M 12.68M 85.15M 33M 413M 33.37M 32.65M 1.43B
Net Debt -17.9M -20.53M -16.58M -15.52M -29.11M -1.94B -29.28M -197M -76.22M -953M -77.06M -75.41M -3.31B -47M -53.91M -43.53M -40.75M -76.42M -5.09B -76.89M -516M -200M -2.5B -202M -198M -8.69B
Logo CROSSJECT
Crossject specializes in manufacturing and marketing needleless drug self-injection. The group provides Zeneo, a prefilled and single-use device that can be used for intradermal, subcutaneous and intramuscular injections.
Employees
-
Trader
Investor
-
Global
-
Quality
-
ESG MSCI
-
LAST HOURS | 40% Discount: The Best Subscriber-Only Tools to Unlock Hidden Opportunities!
d
:
:
SEIZE THE OFFER!